Why the U.S. spends more on healthcare with worse results; Alnylam goes it alone on rare disease therapy; MorphoSys hopes for accelerated approval on MOR208.
Amazon, Berkshire Hathaway, and JPMorgan team up to form a healthcare company; Takeda's Zika vaccine receives FDA fast-track status
The Congressional Budget Office says that Sanders' bill would save the U.S. federal government nearly $7 billion over the next decade.
The FDA delays final rule related to off-label use; Amgen's Repatha reduces risk of death by 20%, study finds; FDA rejects AstraZeneca's hyperkalaemia drug
This event will focus on the wide-ranging application of this thinking in healthcare, identify the latest trends in achieving patient engagement, and share standout examples and new insights.
Rising healthcare costs, coupled with high-profile stories of price gouging at some small pharmaceutical companies, have left consumers feeling ripped off